UW researchers found potential new treatments for a rare pediatric brain cancer each year that has a median survival time of ...

The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

Promising ovarian cancer research by Melanie Rutkowski, PhD, at the University of Virginia Comprehensive Cancer Center has ...

Google DeepMind’s AI, specifically the Gemma model, has played a pivotal role in discovering a new potential pathway for cancer therapy. This breakthrough, which reveals a method to make tumors more ...

Calcipotriol plus 5-FU immunotherapy activates Th2 immunity, releasing IL-24 cytokines to suppress skin cancer development in patients with actinic keratosis. The combination therapy significantly ...

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...

Over the years our annual Pathways to Health Symposium has hosted researchers and community champions to discuss important topics related to cancer health disparities. The Symposium provides a forum ...

Members of the Senate Finance Committee have reintroduced the Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act, a bipartisan bill that would establish a Medicare Coverage pathway to ...

Could diabetes medications have an influence beyond simply regulating blood sugar? This question is gaining ground in ...